Conformal Radiotherapy and Intensity-modulated Radiotherapy: Clinical Data

References

• Leibel SA, Ling CC, Kutcher GJ, Mohan R, Cordon-Cordo C, Fuks Z. The biological basis for conformal three dimen-sional radiation therapy. Int J Radiat Oncol Biol Phys 1991; 21: 805–11.
   PubMed Web of Science ®Google Scholar
• Fuks Z, Horwich A. Clinical and technical aspects of confor-mal therapy. Radiat Oncol 1993; 29: 219–20.
   Web of Science ®Google Scholar
• Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991; 338: 327–31.
   PubMed Web of Science ®Google Scholar
• Kolscielny S, Tubiana M, Le MG, et al. Breast cancer relationship between the size of the primary tumour and the probability of distant dissemination. Br J Cancer 1984; 49: 709–15.
   PubMed Web of Science ®Google Scholar
• Koscielny S, Tubiana M. The link between local recurrence and distant metastases in human breast cancer. Int J Radiat Oncol Biol Phys 1999; 43: 11–24.
   PubMed Web of Science ®Google Scholar
• Fuks Z, Leibel SA, Wallner KE, et al. The effect of local control on metastatic dissemination in carcinoma of the prostate long term results in patients treated with I 125 implantation. Int J Radiat Oncol Biol Phys 1991; 21: 537–47.
   PubMed Web of Science ®Google Scholar
• Leibel SA, Scott CB, Mohiuddin M, et al. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 1991; 21: 549–56.
   PubMed Web of Science ®Google Scholar
• Tubiana M. The role of local treatment in the cure of cancer. Eur J Cancer 1992; 28A: 2061–9.
   PubMed Web of Science ®Google Scholar
• Suit HD. Potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion. Cancer 1982; 50: 1227–34.
   PubMed Web of Science ®Google Scholar
• Suit HD. Local control and patient survival. Int J Radiat Oncol Biol Phys 1992; 23: 653–60.
   PubMed Web of Science ®Google Scholar
• Ramsay J, Suit HD, Sedlacek R. Experimental studies on the incidence of metastases after failure of radiation treatment and the effect of salvage surgery. Int J Radiat Oncol Biol Phys 1988; 14: 1165–8.
   Google Scholar
• Bloom HJ, Wallace WF, Wallace DM, Skeet RG. Treatment of T3 bladder cancer: controlled trial of pre-operative radio-therapy and radical cystectomy vs. radical radiotherapy. Second report and review. Br J Urol 1982; 54: 136–51.
   Google Scholar
• Grisby PW, Perez CA, Camel HM, et al. Stage II carcinoma of the endometrium: results of therapy, and prognostic fac-tors. Int J Radiat Oncol Biol Phys 1985; 11: 1915–23.
   PubMed Web of Science ®Google Scholar
• Anderson P, Dische S. Local tumor control and the subse-quent incidence of distant metastatic disease. Int J Radiat Oncol Biol Phys 1981; 7: 1645–8.
   PubMed Web of Science ®Google Scholar
• Hayward J, Caleffi M. The significance of local control in the primary treatment of breast cancer. Arch Surg 1987; 122: 1244–7.
   PubMedGoogle Scholar
• Arriagada R, Rutqvist LE, Mattsson A, et al. Adequate loco-regional treatment of early breast cancer may prevent secondary dissemination. J Clin Oncol 1995; 13: 2869–78.
   PubMed Web of Science ®Google Scholar
• Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracie radiotherapy for small cell long cancer. N Engl J Med 1992; 327: 1618–24.
   PubMed Web of Science ®Google Scholar
• Atkins H, Hayward JL, Klugman DJ, Wayte AB. Treatment of early breast cancer--a report after ten years of a clinical trial. Br Med J 1972; 2: 423–9.
   PubMed Web of Science ®Google Scholar
• Pignon JP, Bourhis C, Domenge C, et al. Chemotherapy as an adjunct to definitive loco-regional treatment for head and neck squamour all carcinoma. Results of three meta-analysis using individual updated data. Lancet 2000; 355: 949–55.
   PubMed Web of Science ®Google Scholar
• Arriagada R, Mouriesse H, Sarrazin D, et al. Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gus-tave-Roussy Institute and the Margaret Hospital. Int J Radiat Oncol Biol Phys 1986; 11: 1751–7.
   Google Scholar
• Hendry JH, Moore JV. Is the steepness of dose-incidence curves for tumour control or complications due to variation before or as a result of irradiation? Br J Rad 1984; 57: 1045–6.
   PubMed Web of Science ®Google Scholar
• Moore JV, Hendry JH, Hunter RD. Dose-incidence curves for tumour control and normal tissue injury, in relation to the response of clonogenic cells. Radiother Oncol 1983; 1: 143–57.
   Google Scholar
• Morrison R. The results of treatment of cancer of the bladder-a clinical contribution to radiobiology. Clin Ra-diol 1975; 26: 67–75.
   PubMed Web of Science ®Google Scholar
• Porter EH. The statistical dose-cure relationships for irradi-ated tumors. Br J Radiol 1980; 53: 336–45.
   PubMed Web of Science ®Google Scholar
• Zagars GK, Schultheiss TE, Peters LP. Inter-tumor hetero-geneity and radiation dose control curves. Radiother Oncol 1987; 8: 353–62.
   Google Scholar
• Tubiana M, Dutreix J, Wambersie A, Bewley DR. Introduc-tion to radiobiology. London: Taylor & Francis, 1990.
   Google Scholar
• Hanks GE, Martz KL, Diamond JJ. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 1988; 15: 1299–305.
   PubMed Web of Science ®Google Scholar
• Sanguinetti G, Geara FB, Garden AS, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determi-nants of local and regional control. Int J Radiat Oncol Biol Phys 1997; 37: 985–96.
   PubMed Web of Science ®Google Scholar
• Santos JA, Conzalez Cuesta P, De La Fuente I, Carrion JR. Impact of changes in the treatment of nasopharyngeal car-cinoma: an experience of 30 years. Radiother Oncol 1995; 36: 121–7.
   PubMed Web of Science ®Google Scholar
• Perez CA, Devineni VR, Marcial-Vega V, Marks JE, Simp-son JR, Kuick N. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992; 23: 271–80.
   PubMed Web of Science ®Google Scholar
• Yan JH, Qin DX, Hu YH, et al. Management of local residual primary lesion of nasopharyngeal carcinoma (NPC): Are higher doses beneficial? Int .1- Radiat Oncol Biol Phys 1989; 16: 1465–9.
   PubMed Web of Science ®Google Scholar
• Williams MV, Denekamp J, Fowler JF. Dose-response rela-tionships for human tumors: implications for clinical trials of dose modifying agents. Int .1- Radiat Oncol Biol Phys 1984; 10: 1703–7.
   Google Scholar
• Dutreix J, Tubiana M, Dutreix A. An approach to the interpretation of the clinical data on the tumor control probability dose relationship. Radiother Oncol 1988; 11: 239–48.
   Google Scholar
• Cooper JS, Rowe SD, Newall J. Regional stage IV of the nasopharynx treated by aggressive radiotherapy. Int .1- Ra-diat Oncol Biol Phys 1983; 9: 1737–43.
   Google Scholar
• Marks LB, Munley MT, Bentel GC, et al. Physical and biological predictors of changes in whole-lung function fol-lowing thoracic irradiation. Int .1- Radiat Oncol Biol Phys 1997; 39: 563–70.
   PubMed Web of Science ®Google Scholar
• Martel MK, Ten Haken RK, Hazuka MB, et al. Dose-vol-ume histogram and 3D treatment planning evaluation of patients with pneumonitis. Int .1- Radiat Oncol Biol Phys 1994; 28: 575–81.
   PubMed Web of Science ®Google Scholar
• Oetzel D, Schraube P, Hensley F, et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int .1- Radiat Oncol Biol Phys 1995; 33: 455–60.
   PubMed Web of Science ®Google Scholar
• Boersma LJ, Damen EM, de Boer RW, et al. Estimation of overall pulmonary function after irradiation using dose-ef-fect relationship for local functional injury. Radiother Oncol 1995; 36: 15–23.
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Fa-vourable and unfavourable effect on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 2000; 355: 1757–70.
   Google Scholar
• Del Regato JA. Long term curative results of radiotherapy in patients with an inoperable prostatic carcinoma. Radiol-ogy 1979; 131: 291–7.
   PubMed Web of Science ®Google Scholar
• Bagshaw M. Comments on the treatment of prostate cancer by conventional radiation therapy. Int .1- Radiat Oncol Biol Phys 1995; 32: 287–92.
   PubMed Web of Science ®Google Scholar
• Hanks GE, Lee WR, Hanlon AL, et al. Conformal tech-nique dose escalation for prostate cancer: biochemical evi-dence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen 10 ng/ml. Int .1- Radiat Oncol Biol Phys 1996; 35: 862–8.
   Web of Science ®Google Scholar
• Hanks GE, Hanlon AL, Schultheiss TE, et al. Dose escala-tion with 3D conformal treatment: five year outcomes, treat-ment optimization and future directions. Int .1- Radiat Oncol Biol Phys 1998; 41: 501–10.
   PubMed Web of Science ®Google Scholar
• Uhl BM, Teh BS, Butler EB. Intensity-modulated radiation therapy for prostate cancers: the Baylor experience. Proceed-ings of the Conference of 3D Conformal Radiation Therapy and Intensity Modulated Radiation Therapy in the New Millennium. Houston, TX: Baylor College of Medicine, 1999.
   Google Scholar
• Michalski JM, Purdy JA, Harms WB, Bosch WR. 3D con-formal radiation therapy for prostate cancer. An update of RTOG 94-06. Proceeding of the Conference of 3D Confor-mal Radiation Therapy and Intensity Modulated Radiation Therapy in the New Millennium. Houston, TX: Baylor College of Medicine, 1999.
   Google Scholar
• Wazer DT, Di Petrillo T, Tsai JS, Engler M, Godin C, Pagnini P. The New-England medical center prostate cancer IMRT experience. Proceeding of the Conference of 3D Conformal Radiation Therapy and Intensity Modulated Ra-diation Therapy in the New Millennium. Houston, TX: Baylor College of Medicine, 1999.
   Google Scholar
• Roach M, Pickett B, Weil M, Verhey L. The 'critical volume tolerance method' for estimating the limits of dose escalation during three-dimensional conformal radiotherapy for prostate cancer. Int .1- Radiat Oncol Biol Phys 1996; 35: 1019–25.
   PubMed Web of Science ®Google Scholar
• Roach M, Faillace-Akazawa P, Malfatti C, Holland J, Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-di-mensional conformal radiotherapy. Int .1- Radiat Oncol Biol Phys 1996; 35: 1011–8.
   PubMed Web of Science ®Google Scholar
• Roach M, Faillace-Akazawa P, Malfatti C. Prostate volumes and organ movement defined by serial CT scans during 3D conformal radiotherapy. Radiat Oncol Invest 1997; 5: 187–94.
   PubMedGoogle Scholar
• Beard CJ, Kijewski P, Bussière M, et al. Analysis of prostate and seminal vesicle motion: implications for treatment plan-ning. Int .1- Radiat Oncol Biol Phys 1996; 34: 451–8.
   Google Scholar
• Bentel GC, Marks LB, Sherouse GW, Spencer DP, Anscher MS. The effectiveness of immobilization during prostate irradiation. Int J Radiat Oncol Biol Phys 1997; 39: 791–5.
   Web of Science ®Google Scholar
• Hanley J, Lumley MA, Mageras GS, et al. Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 1997; 37: 435–44.
   PubMed Web of Science ®Google Scholar
• Van Herk M, Bel A, Gilhuijs KG, et al. Electronic portal imaging. Bull Cancer 1995; 82 (Suppl 5): 601–6.
   Google Scholar
• Balter JM, Sandler HM, Lam K, Bree RU, Lichter AS, Ten Haken RK. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys 1995; 31: 113–8.
   PubMed Web of Science ®Google Scholar
• Rudat V, Schraube P, Oetzel D, Zierhut D, Flentje M, Wannenmacher M. Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 1996; 35: 1027–34.
   PubMed Web of Science ®Google Scholar
• Huddart RA, Nahum A, Neal A, et al. Accuracy of pelvic radiotherapy: prospective analysis of 90 patients in a ran-domized trial of conformal versus conventional treatment. Radiother Oncol 1996; 39: 19–29.
   PubMed Web of Science ®Google Scholar
• Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radio-therapy in prostate cancer: a randomised trial. Lancet 1999; 353: 267–72.
   PubMed Web of Science ®Google Scholar
• LoSasso TJ, Chui C-S, Kutcher GJ, Leibel SA, Fuks Z, Ling CC. The use of multi-leaf collimator for conformal radio-therapy in carcinomas of the prostate and nasopharynx. Int J Radiat Oncol Biol Phys 1993; 25: 161–70.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41: 491–500.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Fuks Z, Wolfe T, et al. Locally advanced prostatic cancer: long-term toxicity after three-dimensional conformal radiation therapy--a dose-escalation study. Ra-diology 1998; 209: 169–74.
   Google Scholar
• Leibel SA, Fuks Z, Zelefsky MJ, et al. The treatment of localized prostate cancer with three-dimensional conformal and intensity modulated radiation therapy at the Memorial Sloan-Kettering Cancer Center. Proceedings of the Confer-ence of 3D Conformal Radiation Therapy and Intensity Modulated Radiation Therapy in the New Millennium. Houston, TX: Baylor College of Medicine, 1999.
   Google Scholar
• Sandler HM, McLaughlin PW, Ten Haken RK, et al. Three dimensional conformal radiotherapy for treatment of prostate cancer: low risk of chronic rectal morbidity ob-served in a large series of patients. Int J Radiat Oncol Biol Phys 1996; 34: 655–62.
   PubMed Web of Science ®Google Scholar
• Boersma LJ, van den Brink M, Bruce AM, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer using dose-volume histograms. Int .1- Radiat Oncol Biol Phys 1998; 41: 83–92.
   PubMed Web of Science ®Google Scholar
• Lee WR, Hanks GE, Hanlon A, Schultheiss TE, Hunt MA. Lateral rectal shielding reduces late rectal morbidity follow-ing high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. Int .1- Radiat Oncol Biol Phys 1996; 35: 251–7.
   Google Scholar
• Pollack A, Zagars GK, Starkschall G, et al. Conventional versus conformal radiotherapy for prostate cancer: prelimi-nary results of dosimetry and acute toxicity. Int .1- Radiat Oncol Biol Phys 1996; 34: 555–64.
   PubMed Web of Science ®Google Scholar
• Nguyen LN, Pollack A, Zagars GK. Late effects after radiotherapy for prostate cancer in a randomized dose-re-sponse study: results of a self assessment questionnaire. Urology 1998; 51: 991–7.
   Google Scholar
• Koper PC, Stroom JC, Van Putten WL, et al. Acute morbid-ity reduction using 3D-CRT for prostate carcinoma, a ran-domized study. Int .1- Radiat Oncol Biol Phys 1999; 43: 727–34.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Happersett L, Leibel SA, et al. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int .1- Radiat Oncol Biol Phys 1997; 37: 13–9.
   PubMed Web of Science ®Google Scholar
• Fletcher GH. Clinical dose response curve of human epithe-lioma tumors. In: Textbook of radiotherapy. 3rd ed. Philadelphia, PA: Lea & Febiger, 1981: 180–219.
   Google Scholar
• Boyer AL, Geis P, Grant W, Carol M. Modulated beam conformal radiotherapy for head and neck tumors. Int .1-Radiat Oncol Biol Phys 1997; 39: 227–36.
   PubMed Web of Science ®Google Scholar
• Esik O, Berkelbach J, Boesecke R, Schleger W, Nemeth G, Lorenz WJ. Three dimensional photon radiotherapy plan-ning for laryngeal and hypopharyngeal cancers. 2-confor-mation treatment planning using multileaf collimator. Radiother Oncol 1991; 20: 238–44.
   Google Scholar
• Tsai JS, Engler MJ, Ling MN, et al. A non-invasive immobi-lization system and related quality assurance for dynamic intensity modulated radiation therapy of intracranial and head and neck disease. Int .1- Radiat Oncol Biol Phys 1999; 43: 455–67.
   PubMed Web of Science ®Google Scholar
• Tsai JS, Wazer DE, Ling MN, et al. Dosimetric verification of the dynamic intensity-modulated radiation therapy of 92 patients. Int .1- Radiat Oncol Biol Phys 1998; 40: 1213–30.
   PubMed Web of Science ®Google Scholar
• Teh BS, Uhl BM, Butler EB. Intensity modulated radiation therapy for head and neck carcinoma. The Baylor experi-ence. Proceedings of the Conference of 3D Conformal Radi-ation Therapy and Intensity Modulated Radiation Therapy in the New Millennium. Houston, TX: Baylor College of Medicine, 1999.
   Google Scholar
• Wu Q, Manning M, Schmidt-Ullrich R, Mohan R. The potential for sparing parotids and escalation of biologically effective dose with IMRT of head and neck cancers. Int .1-Radiat Oncol Biol Phys 2000; 46: 195–205.
   Google Scholar
• Low DA, Chao KSC, Mutic S, Gerher RL, Perez CA, Purdy JA. Quality assurance of serial tomotherapy for head and neck patient treatments. Int .1- Radiat Oncol Biol Phys 1998; 42: 681–92.
   PubMed Web of Science ®Google Scholar
• Chao KSC, Low DA, Perez CA, Purdy JA. Intensity modu-lated radiation therapy in head and neck cancers. The Mallinckrodt experience. Int .1- Cancer 2000; 90: 92–103.
   PubMed Web of Science ®Google Scholar
• Dawson LA, Anzai Y, Marsh L, Paulino A, Ship J, Eisbruch A. Patterns of local-regional failure following parotid spar-ing conformal radiotherapy and multisegmental intensity modulated radiotherapy for head and neck cancers. Int .1-Radiat Oncol Biol Phys 1999; 45 (Suppl 3): 150 (Abstract).
   Google Scholar
• Sultanem K, Shu HK, Xia P, et al. 3D intensity modulated radiotherapy (IMRT) in the treatment of nasopharyngeal carcinoma: the UCSF experience. Int .1- Radiat Oncol Biol Phys 1999; 45 (Suppl 3): 151 (Abstract).
   Google Scholar
• Teh BS, Chin JK, Woo SY. Intensity modulated radiation therapy (IMRT) for pediatric brain and head and neck tumors. The Baylor experience. Proceedings of the Confer-ence of 3D Conformal Radiation Therapy and Intensity Modulated Radiation Therapy in the New Millennium. Houston, TX: Baylor College of Medicine, 1999.
   Google Scholar
• Augspurger ME, Lee AG, Woo SY. Conformal intensity modulated radiation therapy for the treatment of optic nerve sheath meningioma. The Baylor experience. Proceedings of the Conference of 3D Conformal Radiation Therapy and Intensity Modulated Radiation Therapy in the New Millen-nium. Houston, TX: Baylor College of Medicine, 1999.
   Google Scholar
• Vineberg KA, Martel MK, Kessler MC, et al. Dose escala-tion to 100 ± Gy using automated IMRT optimization. Int .1-Radiat Oncol Biol Phys 1999; 45 (Suppl 3): 270 (Abstract).
   Google Scholar
• Overgaard M, Hansen PS, Overgaard J, et al. Preoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949–55.
   PubMed Web of Science ®Google Scholar
• Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956–62.
   PubMed Web of Science ®Google Scholar
• Hong L, Hunt M, Chui C, et al. Intensity modulated tangen-tial beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys 1999; 44: 1155–64.
   PubMed Web of Science ®Google Scholar
• Lo YC, Yasuda G, Fitzgerald TJ, Vrie MM. Intensity modulation for breast treatment using static multileaf colli-mators. Int J Radiat Oncol Biol Phys 2000; 46: 187–94.
   PubMed Web of Science ®Google Scholar
• Van Rijswijk R, Verbeek J, Haanen C, et al. Major compli-cations and causes of death in patients treated for Hodgkin's disease. J Clin Oncol 1987; 5: 1624–33.
   PubMed Web of Science ®Google Scholar
• Henry-Amar M, Somers R. Survival outcome after Hodgkin's disease: a report from the International Data Base on Hodgkin's disease. Semin Oncol 1990; 17: 758–68.
   Google Scholar
• Vaughan Hudson B, Vaughan Hudson G, Linch D, et al. Late mortality in young British National Lymphoma Investi-gation patients cured of Hodgkin's disease. Ann Oncol 1994; 5: 565–6.
   Google Scholar
• Henry-Amar M, Hayat M, Meerwaldt JH, et al. Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group. Int J Radiat Oncol Biol Phys 1990; 19: 1155–7.
   Google Scholar
• Cosset JM, Henry-Amar M, Meerwaldt J. Long-term toxic-ity of early stage of Hodgkin's disease therapy: the EORTC experience. Ann Oncol 1991; 2: 77–82.
   PubMed Web of Science ®Google Scholar
• Mauch P, Kalish L, Marcus K, et al. Long-term survival in Hodgkin's disease: relative impact of mortality, second tu-mors, infection and cardiovascular disease. Cancer J Sci Am 1995; 1: 33–42.
   PubMedGoogle Scholar
• Hancock S, Hoppe R. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Ra-diat Oncol 1996; 6: 225–42.
   PubMedGoogle Scholar
• Hoppe R. Hodgkin's disease: complications of therapy and excess mortality. Ann Oncol 1997; 8: S115–8.
   PubMed Web of Science ®Google Scholar
• Cosset JM, Henry-Amar M, Pellae-Cosset B, et al. Pericardi-tis and myocardial infarctions after Hodgkin's disease ther-apy. Int J Radiat Oncol Biol Phys 1991; 21: 447–9.
   PubMed Web of Science ®Google Scholar
• Hancock S, Hoppe R. Long-term complications of treatment and cancer mortality after Hodgkin's disease. Semin Radiat Oncol 1996; 6: 225–42.
   PubMedGoogle Scholar
• Hancock S, Tucker M, Hoppe R. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993; 270: 1949–55.
   Google Scholar
• Purdy JA. Future directions in 3D treatment planning and delivery: a physicist's perspective. Int .1- Radiat Oncol Biol Phys 2000; 46: 3–6.
   PubMed Web of Science ®Google Scholar
• Grant W, Woo SY. Clinical and financial issues for inten-sity-modulated radiation therapy delivery. Semin Radiat Oncol 1999; 9: 99–107.
   PubMed Web of Science ®Google Scholar
• Stemick ES, ed. The theory and practice of intensity modu-lated radiation therapy. Madison, WI: Advanced Medical Publishing, 1997.
   Google Scholar
• Verhey U. Comparison of three dimensional conformal radiation therapy and intensity modulated radiation therapy systems. Semin Radiat Oncol 1999; 9: 78–98.
   PubMed Web of Science ®Google Scholar
• Frass BA, Kessler ML, McShan DL, et al. Optimization and clinical use of multi-segment intensity-modulated radiation therapy for high dose conformal therapy. Semin Radiat Oncol 1999; 9: 60–77.
   PubMed Web of Science ®Google Scholar
• Lee JS, Jani AB, Pelizzari CA, et al. Volumetric visualization of head and neck CT data for treatment planning. Int J Radiat Oncol Biol Phys 1999; 44: 693–703.
   PubMed Web of Science ®Google Scholar
• Verhey U. Immobilizing and positioning patients for radio-therapy. Semin Radiat Oncol 1995; 5: 100–14.
   PubMedGoogle Scholar
• Ahnesjo A, Aspradakis MM. Dose calculations for external photon beams in radiotherapy. Phys Med Biol 1999; 44: R99–R155.
   Web of Science ®Google Scholar
• Mohan R, Wang X, Jackson A, et al. The potential and limitations of the inverse radiotherapy technique. Radiother Oncol 1994; 32: 232–48.
   PubMed Web of Science ®Google Scholar
• Purdy JA. Advances in three-dimensional treatment plan-ning and conformal dose delivery. Semin Oncol 1997; 24: 655–71.
   PubMed Web of Science ®Google Scholar
• Meeks SL, Buatti JM, Bova FJ, et al. Potential clinical efficacy of intensity modulated conformal radiotherapy. Int J Radiat Oncol Biol Phys 1998; 40: 483–95.
   PubMed Web of Science ®Google Scholar
• Carol MP. Where we go from here. One person's vision. In: Sternick ES, ed. The theory and practice of intensity modu-lated radiation therapy. Madison, WI: Advanced Medical Publishing, 1997: 243–52.
   Google Scholar
• Thames HD, Schultheiss TE, Hendry JH, Tucker SL, Du-bray BM, Brock WA. Can modest escalations of dose be detected as increased tumor control. Int J Radiat Oncol Biol Phys 1994; 22: 241–6.
   Web of Science ®Google Scholar
• Söderström S, Gustafsson A, Brahme A. Optimization of the dose delivery in few field techniques using radiobiological objective functions. Med Phys 1993; 20: 1201–10.
   Google Scholar